• Novel shows promise in Phase II schizophrenia trial europeanpharmaceuticalreview
    February 26, 2021
    KarXT significantly reduced both positive and negative of symptoms of schizophrenia without the common problematic side effects of current antipsychotic therapies.
PharmaSources Customer Service